Masatsugu Ueda
Comptroller/Controller/Auditor at PHOENIXBIO CO., LTD.
Profile
Masatsugu Ueda is currently working as an Auditor at PhoenixBio Co., Ltd.
He previously worked as a Managing Director at Institute of Immunology Co., Ltd.
and as an MD & Manager-Transgenic Animal Division at PhoenixBio Co., Ltd.
Masatsugu Ueda active positions
| Companies | Position | Start |
|---|---|---|
| PHOENIXBIO CO., LTD. | Comptroller/Controller/Auditor | 31/05/2019 |
Former positions of Masatsugu Ueda
| Companies | Position | End |
|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
| PHOENIXBIO CO., LTD. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHOENIXBIO CO., LTD. | Commercial Services |
| Private companies | 1 |
|---|---|
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Masatsugu Ueda
